Academy of Finland – NIH joint call: thematic areas of the Finnish Research Flagships

25 November 2021
see below for details
up to 5 years
Upcoming
  • In this joint call, the application procedure differs from a typical Academy of Finland call. Please study the procedure in section ‘Background and objectives’ in detail before starting preparations to apply.
  • In this joint call, applicants from Finland can participate in NIH R01 funding opportunities with proposal due dates of 5 February (R01 new) and 5 March 2022 (R01 renewal, resubmission, revision).
  • The Academy is expecting to fund the Finnish components of the collaborative AKA-NIH projects overall with a maximum of 3 million euros in 2022. The maximum funding granted for a five-year project is 750,000 euros. The funding to be distributed through this call depends on the Finnish Parliament’s decision to allocate the necessary funds to the Academy in its budget for 2022.
  • In case of delays in the processing of the applications resulting in the need to commit the Academy’s budget for 2023 to this call, the funding to be distributed will depend on the Finnish Parliament’s decision to allocate the necessary funds to the Academy in its budget for 2023.
  • The ‘Intention to Submit’ is sent by the PI from Finland to the Academy as early as possible and at least eight weeks before the NIH deadline, and the close-to-final draft proposal at least six weeks before the NIH deadline. The final proposal is submitted to the NIH by the US PI.
  • If the total requested funding in the close-to-final draft proposals significantly exceeds the available funding, the Academy will select the proposals it will support and issue ‘Confirmation of Eligibility for Funding’ letters for the selected proposals. After this cut-off stage the Academy may no longer issue new letters, and the call may be closed prematurely. Applicants will be informed about the selections and the possible closing of the call.
  • Academy funding will be granted only for proposals that receive a ‘Confirmation of Eligibility for Funding’ letter from the Academy and are selected for funding in the respective NIH funding call.

The AKA-NIH Partnership Programme, launched in November 2020, is an initiative between the National Institutes of Health (NIH) and the Academy of Finland (AKA). Under the Programme, a ‘single-proposal, single-review’ mechanism is facilitated by the NIH through their existing grants programmes. From the perspective of AKA, all proposals submitted under the auspices of the Partnership must have significant research involvement from researchers from both countries. Funding will be provided for collaborative research activities falling within the missions of participating NIH Institutes and Centers and the thematic areas of AKA Finnish Research Flagships. The Partnership is expected to continue at least until 2023.

The steps in the application procedure for researchers from Finland are as follows:

  1. Notification of Intention to Submit: The Intention to Submit is emailed to AKA at flagship@aka.fi as early as possible and no later than eight weeks before the NIH R01 call deadline. AKA pre-assesses the eligibility of the project. If assessed eligible, the applicant is invited to submit a close‐to‐final draft of the full proposal to AKA.

  2. Draft proposal submission and cut-off stage: The close-to-final proposal must be submitted to AKA no later than six weeks before the NIH R01 call deadline. Following submission of the close-to-final draft proposal, AKA will assess the proposal and, if supportive, provide a ‘Confirmation of Eligibility for Funding’ letter to the Finnish applicant for inclusion in the full proposal submission to the NIH.

If the total requested funding in the close-to-final draft proposals significantly exceeds the available maximum funding of 3 million euros, AKA will select the proposals it will support and issue ‘Confirmation of Eligibility for Funding’ letters for the selected proposals. After this cut-off stage AKA may no longer issue new letters, and the call may be closed prematurely.

  1. Submitting application to the NIH: The US proposer submits the final proposal including the ‘Confirmation of Eligibility for Funding’ letter to the appropriate NIH programme for review. The proposal is reviewed in accordance with the standard NIH merit review criteria of intellectual merit and broader impacts of the proposed effort. AKA has agreed to accept the assessments of the NIH with regard to the suitability for funding of individual proposals.

The application procedure, which should be studied in detail before starting preparations to apply, is described in detail in the section ‘Background and objectives’.

The requirements in this call announcement relate only to applicants applying for funding from AKA.

Before you fill in the application in the online services (SARA), carefully read the call text and the ‘Read more’ section, especially the funding terms and conditions. If the call text and the funding terms and conditions conflict, the terms and conditions should always be considered primary. This call text is published only in English.

Read the full call text on this page.

Open all

Do you have questions or feedback for us?